Skip to content

This is a clinical trial wherein the efficacy and safety of Curcumin will be studied in Canker sore and gingivitis.

A prospective,open label,two arm clinical study to evaluate the efficacy and safety of C3 Reduct ODN in the treatment of canker sore and gingivitis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/01/007670
Enrollment
60
Registered
2017-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K05- Gingivitis and periodontal diseases Health Condition 2: K137- Other and unspecified lesions of oral mucosa

Interventions

Intervention1: C3 Reduct ODN.: One tablet of C3 Reduct ODN twice daily in the treatment of Canker sore with throat pain and Gingivitis. Control Intervention1: NIL: NIL

Sponsors

Sami Labs Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Healthy male and or female with no systemic disease. 2 Age between 18 to 60 years. 3 Having mouth ulcers with throat pain or Patients with mild to moderate gingivitis. 4 Patients having erupted teeth. 5 Willing to come for regular follow-up visits. 6 Able to give written informed consent.

Exclusion criteria

Exclusion criteria: 1 Smokers. 2 Presence of any systemic hematological problems. 3 Drug or alcohol abuse. 4 Under systemic or topical corticosteroid therapy. 5 Pregnant women or lactating mothers 6 History of HIV and other viral infections. 7 History of any antibiotic therapy in past 3 months. 8 History of oral prophylaxis within 6 months previous to the study 9 Patients with mouth breathing habit. 10 Patients using orthodontic and prosthodontics appliances 11 Are on analgesics or antiseptics. 12 Patients who have received any periodontal therapy in the past 6 months.

Design outcomes

Primary

MeasureTime frame
For Canker sore with throat pain - Number of ulcers healed,VAS Pain Scale,Ulcer size reduction,Duration of complete healing of ulcers, Clinical Photographs of the Lesion,Throat Numbness Scale,Sore Throat Relief Scale(Screening,Day14 & Day21). For Gingivitis -Loe and Silness Gingival index,Subjective and objective criteria for Gingivitis. â?¢Clinical Photographs of gingival region.Timepoint: For Canker sore with throat pain - Number of ulcers healed,VAS Pain Scale,Ulcer size reduction, Duration of complete healing of ulcers, Clinical Photographs of the Lesion,Throat Numbness Scale,Sore Throat Relief Scale (Screening,Day14 & Day21). For Gingivitis - Loe and Silness Gingival index, Subjective and objective criteria for Gingivitis,Clinical Photographs of gingival region(Screening,Day14 & Day 21).

Secondary

MeasureTime frame
â?¢Any reports of adverse or serious adverse events. â?¢Abnormal vital signs& lab parameters.Timepoint: â?¢Any reports of adverse or serious adverse events(Day 14 & Day 21). â?¢Abnormal vital signs (Screening,Day 14 & Day 21)& lab parameters (Screening & Day 21).

Countries

India

Contacts

Public ContactMr Chandu Devanpally

ClinWorld(P)Limited

kiran@clinworld.org08028397973

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026